Getting to BIDMC    Contact BIDMC    617-667-7000

Events Calendar    News    CAREERS @ BIDMC

ABOUT BIDMC CENTERS & DEPARTMENTS PATIENT & VISITOR INFORMATION YOUR HEALTH QUALITY & SAFETY MEDICAL EDUCATION RESEARCH GIVE TO BIDMC
 

BIDMC Research Investigator / Faculty Information

Kenneth A Bauer MD

Professor

Hemostasis Thrombosis

Faculty Appointment:

Hematology and Oncology

Hemostasis Thrombosis

 

Contact Information:

 
Title:   Physician Professor
Office:   KS-132
Phone:   667-2174
Fax:   617-738-1450
Email:   kbauer@bidmc.harvard.edu
Address:   Beth Israel Deaconess Medical Center
 330 Brookline Ave; KS-132
 Boston, MA 02215

Advanced Degree And Training Info:

Year

Institution

Area or Rank

1975  Stanford University School of Medicine  Medicine
1975  University of Chicago Hospitals and Clinics  Medical Intern/Resident
1978  Harvard Medical School  Clinical/Research Fellow
1982  Harvard Medical School  Instructor
1984  Harvard Medical Shool  Assistant Professor
1991  Harvard Medical School  Associate Professor
2004  Harvard Medical School  Professor

Research Team Listing

Marie Mahony RN

Areas of Interest:

Cancer & Hematologic

Patient Oriented / Translational   

Major Research Theme:

Clinical research in thrombosis and development of new anticoagulants for prevention and treatment of established venous and arterial thrombosis

Select Major Publications:    List of Publications via PubMed database at NIH NLM

Bauer KA. New Anticoagulants.  Curr Opin Hematol. 2008; 15:509-515
Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest 2008; 133 (6 Suppl):141S-159S.
Bauer KA.  In Hematology: Basic Principles and Practice, 4th Edition.  Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave, P, eds.  Hypercoagulable states, Elsevier Churchill Livingstone, Philadelphia, 2005; pp. 2197-2224
Bauer KA, Eriksson BI, Lassen MR, Turpie AGG for the Steering Committee of the Pentasaccharide in Major Knee Surgery Study.  Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.  N Eng J Med 2001; 345:1305-1310
Bauer KA. The thrombophilias: Well-defined risk factors with uncertain therapeutic implications. Ann Intern Med. 2001; 135:367-373

External Recognition:

1996-2009    Member of Council, International Society on Thrombosis and Haemostasis (ISTH)
1996-2000    Chairman, Subcommittee on Predictive Haemostatic Variables in Vascular Diseases,
                   Scientific and Standardizaton Committee (SSC) of the ISTH
1997-2003        Member, Committee on Clinical Lipidology and Thrombosis, AHA
1998-2002        Steering Committee Member, Phase III Clinical Trials of Fondaparinux in Major Orthopedic Surgery
2002                Organizing Committee Chairman, 48th Annual Scientific and Standardization Committee Meeting of the ISTH
2002-2004    Secretary/Chairman-Elect of Council, ISTH
2004-2006    Chairman of Council, ISTH
2009              Vice-President and Scientific Program Chair (Clinical), 22nd Congress of the ISTH (Boston, MA USA)

Major Collaborative Activities:

Chief, Hematology Section - VA Boston Healthcare System
Director, Thrombosis Clinical Research, BIDMC

Investigator's Web Site:

             

Harvard Catalyst Site:

   
 

Copyright 2009 Beth Israel Deaconess Medical Center | Contact Research Webmaster

IP Address: 38.107.191.87   |  Web Server: research.bidmc.harvard.edu   |  Database Server: Colorado\SQL17   |  App Path: /research/ResearchPIInfo.ASP   |  Version:

Browser: CCBot/1.0 (+http://www.commoncrawl.org/bot.html)
SecurityGroup: